The cancer risk from smoking is extremely significant. When tobacco is burned, it generates thousands of chemicals, including dozens of well-known carcinogens. Eliminate combustion, and the toxicological makeup changes dramatically.
Research on nicotine, cancer risk, and reduced-risk products has been, once again, clouded by a wave of dubious science and magnified media narratives. A crux of this confusion is a chronic inability to separate the deleterious effects of combustion from the pharmacological actions of nicotine itself—two fundamentally distinct phenomena that should never, ever be conflated on serious public health terms.
An ever-increasing body of evidence continues to strengthen a vital point: The cancer risk from smoking is extremely significant. When tobacco is burned, it generates thousands of chemicals, including dozens of well-known carcinogens. Eliminate combustion, and the toxicological makeup changes dramatically. This is the rationale behind tobacco harm reduction — and it is a principle backed by decades of scientific evidence.
Debunking misleading claims about vaping and cancer risk
At the core of the critique is a bedrock scientific principle: dose matters. Modern analytical techniques can detect tiny traces of chemicals — often at levels so low they pose no meaningful health threat. At best, we give the misleading impression that being present alone is evidence of carcinogenicity, without providing any perspective on levels of exposure. As Hajek points out, a number of the studies on which these reviews draw depend on unrealistic laboratory conditions, such as overheating e-liquids to levels that do not match normal vaping behaviour.
More importantly, these reviews rarely mention the comparison that really matters — again, vaping versus smoking. When that comparison is drawn, the contrast is stark. Studies have consistently found that harmful and potentially carcinogenic compounds from vaping are just a small fraction of those associated with combustible cigarettes. Certain toxicants in cigarette smoke are not present in vapour.
Nicotine is not the enemy
These findings support earlier toxicological predictions, including those in Tobacco Control, which calculated the cancer potency of emissions from vapourized nicotine products to be several orders of magnitude lower than that from cigarette smoke. These findings aren’t controversial among scientists — they’re fundamental.
Misinterpreted studies and the cancer debate
Shahab’s critique of the Carcinogenesis review is even more scathing, pointing out that no common systematic review guidelines exist. Without clear inclusion criteria, pre-registered methodologies (which publicly state how a review will be undertaken), and transparent data selection, such reviews are particularly subject to bias. Effectively, their potential lies in moving into the realm of policy statements rather than evidence synthesis.
Changes made to the original protocol for the study, particularly those that permitted the inclusion of animal studies, non-peer-reviewed abstracts, and smoking-confounded data, introduced tremendous bias, wrote Arielle Selya. The lack of clear disclosures and justifications for these changes suggests a failure of integrity not just in the process but in the review itself.
Flawed science and false narratives
This distinction is critical. Cancer does not develop overnight; it takes years, if not decades. Studies that do not control for a history of smoking or the timing of product use “risk inferring causation when none exists.” Existing disease drives or changes behaviour — not the reverse is much more likely, Siegel writes.
This is particularly disturbing because there is a wealth of evidence that suggests vaping should be used as a smoking cessation tool. Vapes are more successful than traditional nicotine replacement therapies at helping smokers quit, according to multiple independent reviews. By providing nicotine without burning, they satisfy the chemical dependence as well as behavioural aspects of smoking.
How misinformation is undermining tobacco harm reduction
Sadly, the ongoing debate is increasingly driven by what some experts call systemic bias against harm reduction. As Siegel points out, researchers are not immune to dominant narratives and assumptions. And when those narratives favour abstinence-only treatment, they can overshadow, dismiss, or distort evidence for other approaches.
Fact vs fiction
In the end, the science on this matter isn’t unclear or partial. Smoking causes cancer due to combustion. Nicotine, though addictive, does not. Vaping is a reduced-risk product that has a significant potential to facilitate smoking cessation, as supported by toxicological, clinical, and real-world evidence.
